Mark Identification

MICROMET

Serial Number

76444543

Filing Date

Aug 28, 2002

Registration Date

Nov 15, 2005

Trademark by

MICROMET AG

Classification Information

Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives all for scientific purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with florescence activated cell sorting FACS devices or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes

Chemicals

Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases,osteoporosis, graft versus host and host versus graft diseases, transplant rejection,coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders,neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases,proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases; and minimal residual diseases; restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis,immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use, eukaryotic cells,eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture and, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micro metastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples, of cells isolated with FACSor with receptor/ligand binding, of cells of chemically fixed tissue, of micrometasttic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto immune diseases,inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases,restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy,rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases,neurodegenerative diseases; sanitary preparations for medical purposes, namely, agents for dental care

Pharmaceuticals

Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, fluorescence activated cell sorting FACS devices, lasers, balloon instruments and magnetic devices, for scientific research purposes, all for the development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

Electrical and Scientific Apparatus

Diagnostic and testing apparatus and systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting FACS devices, lasers, balloon instruments and magnetic devices, for clinical medical purposes, all for the clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material

Medical Apparatus

Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

Computer and Scientific